NGR1 treatment significantly downregulated the increased TGF-β1 and collagen I protein levels (p < 0.05), indicating that NGR1 suppressed pathological changes of DN via inhibition of the TGF-β pathway. The gene discussed is RTN4R; the disease is liver dysplastic nodule.